Erinaco Company

The Erinaco company is focused
on the development of innovation
therapy approaches for
lung diseases

Our aim is to
make patient
therapy easy
and effective

We use up-to-date
knowledge

slide-1
New approaches
for lung diseases
treatment discovery
New medicines research
and development
Drugs for lung diseases
treatment registration
and launch
Russian pulmonology
scientific potential
development

About the company


Erinaco company was founded in 2016 in Moscow. We are focused on the research and development of the new treatment approaches. Our priority is Pulmonology.

Russian companies produce “rescue medications” mainly, which used during the exacerbations period and in the hospitals and are not used for the maintenance treatment. Medicines for the pulmonary diseases maintenance treatment are produced by the foreign companies.

There is huge unmet need in the development and production of domestic, innovative and qualitative medicines for pulmonary diseases in Russia.

+ Read more

About us

Our history

  1. Company registration.
    First patent received.

  2. Development start in the frames of the first project. Asthma and COPD focus

  3. First results received.

  4. Consultations with the pulmonology key opinion leaders.

  5. PCT patent procedure submission.

  6. We have a new website.

  1. 2016

    Company registration.
    First patent received.

  2. 2016

    Development start in the frames of the first project. Asthma and COPD focus

  3. 2017

    First results received.

  4. 2017

    Consultations with the pulmonology key opinion leaders.

  5. 2017

    PCT patent procedure submission.

  6. 2018

    We have a new website.

Address


3 Molodejnaya str, place XVII, office 6A,

Russia, 119 296, Moscow

Contact us


info@erinaco.es